AU2002352474A1 - Dopamine d1 receptor agonist pro-drug compounds and derivatives - Google Patents

Dopamine d1 receptor agonist pro-drug compounds and derivatives

Info

Publication number
AU2002352474A1
AU2002352474A1 AU2002352474A AU2002352474A AU2002352474A1 AU 2002352474 A1 AU2002352474 A1 AU 2002352474A1 AU 2002352474 A AU2002352474 A AU 2002352474A AU 2002352474 A AU2002352474 A AU 2002352474A AU 2002352474 A1 AU2002352474 A1 AU 2002352474A1
Authority
AU
Australia
Prior art keywords
dopamine
derivatives
receptor agonist
drug compounds
agonist pro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002352474A
Inventor
Gary Stuart Tilbrook
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shire Pharmaceutical Development Ltd
Original Assignee
Shire Pharmaceutical Development Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shire Pharmaceutical Development Ltd filed Critical Shire Pharmaceutical Development Ltd
Publication of AU2002352474A1 publication Critical patent/AU2002352474A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002352474A 2001-12-20 2002-12-19 Dopamine d1 receptor agonist pro-drug compounds and derivatives Abandoned AU2002352474A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0130576.2A GB0130576D0 (en) 2001-12-20 2001-12-20 Dopamine D1 receptor agonist pro-drug compounds & derivatives
GB0130576.2 2001-12-20
PCT/GB2002/005809 WO2003053936A1 (en) 2001-12-20 2002-12-19 Dopamine d1 receptor agonist pro-drug compounds & derivatives

Publications (1)

Publication Number Publication Date
AU2002352474A1 true AU2002352474A1 (en) 2003-07-09

Family

ID=9928104

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002352474A Abandoned AU2002352474A1 (en) 2001-12-20 2002-12-19 Dopamine d1 receptor agonist pro-drug compounds and derivatives

Country Status (3)

Country Link
AU (1) AU2002352474A1 (en)
GB (1) GB0130576D0 (en)
WO (1) WO2003053936A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070232590A1 (en) * 2004-06-18 2007-10-04 Glaxo Group Limited 3-Cylcoalkylbenzazepines as Histamine H3 Antagonists

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1561305A (en) * 1975-07-02 1980-02-20 Smithkline Corp Benzazepine derivatives and pharmeceutical compositions containing them
US4052506A (en) * 1975-08-05 1977-10-04 Smithkline Corporation Pharmaceutical compositions and method of producing anti-parkinsonism activity
DK325188D0 (en) * 1988-06-15 1988-06-15 Novo Industri As BENZAZEPINE DERIVATIVES UNKNOWN
US4861771A (en) * 1989-01-27 1989-08-29 Smithkline Beckman Corporation Carbamates of 6-chloro-7,8-dihydroxy-1-(4'-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine as prodrugs
DK23392D0 (en) * 1992-02-24 1992-02-24 Novo Nordisk As Heterocyclic Compounds, Their Uses and Preparation
GB9903671D0 (en) * 1999-02-17 1999-04-14 Cenes Ltd Dopamine D-1 receptor agonist compounds

Also Published As

Publication number Publication date
WO2003053936A1 (en) 2003-07-03
GB0130576D0 (en) 2002-02-06

Similar Documents

Publication Publication Date Title
AU2002210782A1 (en) Amide derivatives as nmda receptor antagonists
AU2003259229A1 (en) CRYSTALLINE Beta2 ADRENERGIC RECEPTOR AGONIST
AU2003290700A1 (en) Farnesoid x receptor agonists
AU2708901A (en) Compounds exhibiting thrombopoietin receptor agonism
AU2001231664A1 (en) Indol-3-yl derivatives
AU775774C (en) Peroxisome proliferator-activated receptor agonist
AU4098501A (en) Estrogen agonist/antagonist metabolites
IL161997A0 (en) Pharmaceutical composition comprising a 5ht1 receptor agonist
AU1652601A (en) New combination comprising a beta2-adrenoreceptor agonist and a leukotriene receptor antagonist
AU2003218660A1 (en) Benzenesulfonamide derivatives and their use as dopamine d3 and d2 receptor liga ds
AU2001240097A1 (en) G protein-coupled receptors
AU2003248356A1 (en) Beta3-adrenergic receptor agonists
AU2003244313A1 (en) Androgen receptor agonist
IL144810A0 (en) Dopamine d1 receptor agonist compounds
AU2002223502A1 (en) Glucagon antagonist/inverse agonist
AU2002352474A1 (en) Dopamine d1 receptor agonist pro-drug compounds and derivatives
AU1100300A (en) Piperidyloxadiazoles as dopamine receptor antagonists
AU2001249922A1 (en) G protein-coupled receptors
AU2003297408A1 (en) Thiazole compounds as integrin receptor antagonists derivatives
AU4262799A (en) Tetraisoquinololine derivatives as modulators of dopamine d3 receptors
AU2002302774A1 (en) Macrophage receptor agonist or antagonist
GB0020710D0 (en) Dopamine D1 receptor agonist pro-drug compounds & derivatives
AU2003289708A1 (en) Calibration rig
AU2001257231A1 (en) Novel g protein-coupled receptors
AU2000243515A1 (en) Association of beta2-adrenergic receptor haplotypes with drug response

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase